1. 354 A phase 1 trial of CUE-101 a novel HPV16 E7-pHLA-IL2-Fc fusion protein in patients with recurrent/metastatic HPV16+ head and neck cancer. (9th November 2020) Authors: Pai, Sara; Adkins, Douglas; Wirth, Lori; Chung, Christine; Gibson, Michael; Sukari, Ammar; Worden, Francis; Colevas, Dimitrios; Saba, Nabil; Burtness, Barbara; Rodriguez, Cristina; Bauman, Julie; Glisson, Bonnie; Dunn, Lara; Suri, Anish; Haydock, Mark; Quayle, Steven; Cemerski, Saso; Leader, Mega... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A216 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗